+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anti Rheumatic"

Rheumatoid Arthritis Treatment - Global Strategic Business Report - Product Thumbnail Image

Rheumatoid Arthritis Treatment - Global Strategic Business Report

  • Report
  • December 2025
  • 274 Pages
  • Global
From
Tenosynovitis Drugs Market Report 2025 - Product Thumbnail Image

Tenosynovitis Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Anti-Inflammatory Drugs Global Market Report 2025 - Product Thumbnail Image

Anti-Inflammatory Drugs Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Ankylosing Spondylitis Market Report 2025 - Product Thumbnail Image

Ankylosing Spondylitis Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Upadacitinib Global Market Report 2025 - Product Thumbnail Image

Upadacitinib Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Musculoskeletal Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Musculoskeletal Drugs Market - Global Strategic Business Report

  • Report
  • December 2025
  • 286 Pages
  • Global
From
From
From
From
Psoriatic Arthritis Market Report and Forecast 2025-2034 - Product Thumbnail Image

Psoriatic Arthritis Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

The Anti Rheumatic market is a subset of the Immune Disorders Drugs market, which focuses on the treatment of rheumatic diseases. These diseases are caused by an abnormal immune response, which can lead to inflammation and joint pain. Anti Rheumatic drugs are used to reduce inflammation and pain, as well as to prevent further damage to the joints. These drugs can be administered orally, intravenously, or topically. Commonly used Anti Rheumatic drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and biologic response modifiers. Some companies in the Anti Rheumatic market include AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more